Q1 2019

Filed May 8, 2019 · 10-Q · 38 days after period end · 0001564590-19-017318

Q1 2019 · 10-Q

Revenue

$379.00K

±0.0% vs Q1 2018

Net Income

-$14.30M

N/M vs Q1 2018

EPS Diluted

-$0.53

N/M vs Q1 2018

Operating Income-$14,811,000N/M

Operating Cash Flow

Same quarter

Metric	Q1 2019	Q1 2018	Q1 2017	Q1 2016
Revenue	$379.00K	$379.00K	$305.00K	$305.00K
Net Income	-$14.30M	-$19.40M	-$12.97M	-$10.33M
EPS Diluted	-$0.53	$0.79	-$2.85	-$2.85

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Syndax Pharmaceuticals Inc · CIK 1395937 · Engraved from SEC EDGAR